Abnormal behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
910
|
121
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Abnormal pigmentation
|
phenotype |
|
Finding
|
58
|
5
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of the cerebral vasculature
|
disease |
|
Anatomical Abnormality
|
18
|
|
0.100 |
None |
|
0 |
|
|
|
Acinar Cell Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
65
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
CUI: |
C0702166 |
Disease: |
Acne
|
Acne
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
167
|
11
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Acquired Protein S Deficiency
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
4
|
|
0.020 |
None |
0.500 |
2 |
|
2010 |
2013 |
Acquired purpura fulminans
|
phenotype |
Pathological Conditions, Signs and Symptoms; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
1993 |
1993 |
Activated Protein C Resistance
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
41
|
30
|
0.400 |
None |
1.000 |
12 |
1
|
1994 |
2015 |
Acute alcoholic liver disease
|
disease |
Digestive System Diseases; Chemically-Induced Disorders; Mental Disorders
|
Disease or Syndrome
|
35
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Acute myocardial infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
766
|
118
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.050 |
None |
1.000 |
5 |
|
1990 |
2019 |
Adenocarcinoma of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
342
|
108
|
0.100 |
None |
1.000 |
11 |
|
1999 |
2019 |
Adenoma
|
group |
Neoplasms
|
Neoplastic Process
|
1183
|
103
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Adenomatous Polyposis Coli
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
609
|
237
|
0.010 |
None |
1.000 |
1 |
|
1997 |
1997 |
Adult Non-Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
370
|
39
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Advanced Prostate Carcinoma
|
disease |
|
Neoplastic Process
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Age-related cognitive decline
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
24
|
3
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
aggressive cancer
|
phenotype |
|
Neoplastic Process
|
83
|
5
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Alveolar Bone Loss
|
disease |
Musculoskeletal Diseases; Stomatognathic Diseases
|
Disease or Syndrome
|
101
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Alzheimer's Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
3397
|
1843
|
0.030 |
None |
1.000 |
3 |
|
1991 |
2019 |
Anaplasia
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
538
|
7
|
0.010 |
None |
< 0.001 |
1 |
|
2000 |
2000 |
Anastomosis
|
disease |
|
Acquired Abnormality
|
155
|
2
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
androgen independent prostate cancer
|
disease |
|
Neoplastic Process
|
190
|
5
|
0.010 |
None |
< 0.001 |
1 |
|
2005 |
2005 |
Antiphospholipid Syndrome
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
99
|
17
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Antithrombin III Deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
27
|
52
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |